Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced no production in raw 264.7 macrophages via the adrenergic receptors

Journal of Physiology and Pharmacology

Volumn 60, Issue 1, 2009, Pages 143-150

  Pekarova, M ^a   Kralova, J ^a   Kubala, L ^a   Ciz, M ^a   Papezikova, I ^a   Macickova, T ^b   Pecivova, J ^b   Nosal, R ^b   Lojek, Antonin ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Adrenergic agonists; Adrenergic antagonists; Carvedilol; Macrophages; Nitric oxide

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; ATENOLOL; CARVEDILOL; DOPAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRITE; NORADRENALIN; PRAZOSIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADRENERGIC AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROPANOLAMINES; RECEPTORS, ADRENERGIC; SIGNAL TRANSDUCTION;

EID: 65949108806     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Pecivova J, Macickova T, Lojek A et al. In vitro effect of carvedilol on professional phagocytes. Pharmacology 2007; 79: 86-92.
2. Nosal R, Jancinova V, Ciz M, Drabikova K, Lojek A, Fabryova V. Inhibition of chemiluminiscence by carvedilol in the cell-free system, whole human blood and blood cells. Scand J Clin Lab Incest 2005; 65: 55-64. (Pubitemid 40278312)
3. Hasko G. Receptor-mediated interaction between the sympathetic nervous system and immune system in inflamation. Neurochem Res 2001; 26:1039-1044. (Pubitemid 33021430)
4. Fleming I, Busse R. The physiology of nitric oxide: Control and consequences. Curr Med Chem-Anti-Inflamm & Anti- Allergy Agents 2004; 3: 189-205. (Pubitemid 39157798)
5. Gadek-Michalska A, Bugajski J. Nitric oxide in the adrenergic- and CRH-induced activation of hypothalamicpitutary- adrenal axis. J Physiol Pharmacol 2008; 59: 365-378.
6. Gonzales-Luis G, Fletcher AJW, Moreno L, Perez-Vizcaino F, Blanco CE, Villamor E. Nitric oxide-mediated nonadrenergic noncholinergic relaxation of piglet pulmonary arteries decreases with postnatal age. J Physiol Pharmacol 2007; 58: 45-56. (Pubitemid 350021136)
7. Bernatowa I, Csiymadiova Z, Kopincova J, Puzserova A. Vascular function and nitric oxide production in chronic social-stress-exposed rats with various family history of hypertension. J Physiol Pharmacol 2007; 58: 487-501. (Pubitemid 47523092)
8. Lawrence DA, Kim D. Central/peripheral nervous system and immune responses. Toxicology 2000; 142: 189-201. (Pubitemid 30009870)
9. Sigola LB, Zinyama RB. Adrenaline inhibits macrophage nitric oxide production trought β1 and β2 adrenergic receptors. Immunology 2000; 100: 359-363. (Pubitemid 30449950)
10. Simski M, Lewandowski J, Abramczyk P, Narkiewicz K, Gaciong Z. Why study sympathetic nervous system? J Physiol Pharmacol 2006; 57: 79-92. (Pubitemid 46569834)
11. Szelenyi J, Selmeczy Z, Brozik A, Medgyesi D, Magocsi M. Dual β-adrenergic modulation in the immune system: Stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochem Int 2006; 49: 94-103. (Pubitemid 43669146)
12. 2- and β- adrenoreceptors in mice. J Neuroimmunol 2000; 103: 34-40.
13. Boomershine ChS, Lafuse WP, Zwilling BS. β2-adrenergic receptor stimulation inhibits nitric oxide generation by Mycobacterium avium infected macrophages. J Neuroimmunol 1999; 101: 68-75. (Pubitemid 29505175)
14. Hasko G, Nemeth ZH, Szabo C, Zsilla G, Salzman AL, Vizi ES. Isopreterenol inhibits IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages. Brain Res Bull 1998; 45: 183-187. (Pubitemid 28027802)
15. Farmer P, Pugin J. β-adrenergic agonists exert their "antiinflammatory" effect in monocytic cells trough the IκB/NF- κB pathway. Am J Physiol Lung Cell Mol Physiol 2000; 279: L675-L682.
16. Hasko G, Szabo C, Nemeth ZH, Deitch EA. Dopamine suppress IL-12 p40 production by lipopolysaccharidestimulated macrophages via a β-adrenoreceptor-mediated mechanism. J Neuroimmunol 2002; 122: 34-39. (Pubitemid 34075488)
17. Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens Suppl 1993; 11: 41-48. (Pubitemid 23226738)
18. Packer M, Fowler MB, Roecker EB et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194-2199. (Pubitemid 35222212)
19. Gomes A, Costa D, Lima JL, Fermnandes E. Antioxidant activity of β-blockers: An effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem 2006; 14: 4568-4577. (Pubitemid 43728661)
20. Lojek A, Pecicova J, Macickova T, Nosal R, Papezikova I, Ciz M. Effect of carvedilol on the production of reactive oxygen species by HL-60 cells. Neuro Endocrinol Lett 2008 (in press).
21. Yue TL, Cheng HY, Lysko PG et al. Carvedilol, a new vasodilator and beta adrenoreceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992; 263: 92-98.
22. Asbrink S, Zickert A, Bratt J, Gyllenhammar H, Palmblad J. No effect of carvedilol on nitric oxide generation in phagocytes at modulation of production of superoxide iNOS. Biochem Pharmacol 2000; 59: 1007-1013. (Pubitemid 30110817)
23. Yue T, McKenna PJ, Lysko PG, Ruffolo RR, Feuerstein GZ, Carvedilol, a new antihypertensive agent, prevents oxidation of human low density lipoprotein by macrophages and cooper. Atherosclerosis 1992; 97: 209-216.
24. Ciz M, Pavelkova M, Gallova L et al. The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW264.7. Physiol Res 2008; 57: 393-402.
25. Hrbac J, Gregor C, Machova M et al. Nitric oxide sensor based on carbon fiber covered with nickel porphyrin layer deposited using optimized electropolymerization procedure. Bioelectrochemistry 2007; 71: 46-53. (Pubitemid 47380483)
26. Brown SW, Meyers RT, Brennan KM et al. Catecholamines in a macrophages cell line. J Neuroimmunol 2003; 135: 47-55.
27. Carreira RS, Monteiro P, Goncalves LM, Providencia LA. Carvedilol: Just another beta-blocker or a powerful cardioprotector? Cardiovasc Hematol Disord Drug Targets 2006; 6: 257-266.
28. Yang SH, Ho LJ, Cheng SM et al. Carvedilol differentially regulates cytokine production from activated human peripheral blood mononuclear cells. Cardivasc Drug Ther 2004; 18: 183-188. (Pubitemid 38918952)
29. Kurum T, Tatli E, Yuksel M. Effect of carvedilol on plasma levels of pro-inflammatory cytokines. Tex Heart Indy J 2007; 34: 52-59.
30. Eiserich JP, Baldus S, Brennan ML et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002; 296: 2391-2394. (Pubitemid 34734213)
31. Severn A, Rapson NT, Hunter CA, Liew FY. Regulation of tumor necrosis factor production by adrenaline and betaadrenergic agonists. J Immunol 1992; 148: 3441-3445.
32. Chen CC, Chiu KT, Sun YT, Chen WC. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharideinduced nitric oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1999; 274: 31559-31564. (Pubitemid 129501612)
33. Lalli E, Sassone-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. J Biol Chem 1994; 269: 17359-17362. (Pubitemid 24218002)
34. Bulut V, Severn A, Liew FY. Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem Biophys Res Commun 1993; 195: 1134-1138. (Pubitemid 23280533)
35. Felten SY, Madden JA, Bellinger SL, Kruszewska B, Moynihan JA, Felten DL. The role of the sympathetic nervous system in the modulation of immune response. Adv Pharmacol 1998; 42: 583-587.
36. Castro P, Vukasovic JL, Chiong M et al. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure. Eur J Heart Fail 2005; 7: 10033-11039 (Pubitemid 41443599)
37. Kawai K, Qin F, Shite J, Mao W, Fukuoka S, Liang CS. Importance of antioxidant and antiapoptotic effects of betareceptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol 2005; 287: H1003-H1012.
38. McKenna F, McLaughlin PJ, Lewis BJ et al. Dopamine receptors expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 2002; 132: 34-40. (Pubitemid 35333323)
39. Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Arcidiacono D. Leon A. Dopamine inhibits responces of astroglia-enriched cultures to lipopolysaccharide via a betaadrenoreceptor- mediated mechanism. J Neuroimmunol 2004; 150: 29-36. (Pubitemid 38481645)